本页面由Tiger Trade Technology Pte. Ltd.提供服务

Vera Therapeutics, Inc.

28.14
-1.7400-5.82%
成交量:49.50万
成交额:1,419.89万
市值:20.18亿
市盈率:-4.77
高:29.49
开:29.11
低:28.14
收:29.88
52周最高:56.05
52周最低:23.05
股本:7,171.39万
流通股本:5,239.41万
量比:0.34
换手率:0.94%
股息:- -
股息率:- -
每股收益(TTM):-5.8984
每股收益(LYR):-4.6644
净资产收益率:-91.75%
总资产收益率:-46.76%
市净率:4.95
市盈率(LYR):-6.03

数据加载中...

2026/09/15

重要事件披露

Form 8-K - Current report
2026/09/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/11

重要事件披露

Form 8-K - Current report
2026/08/07

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/30

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/09

重要事件披露

Form 8-K - Current report
2026/07/07

重要事件披露

Form 8-K - Current report
2026/06/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/02

重要事件披露

Form 8-K - Current report
2026/05/27

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/04/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/01

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/09

重要事件披露

Form 8-K - Current report
2026/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans